IVERIC bio, Inc. (ISEE) Social Stream
IVERIC bio Inc (ISEE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ISEE.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
ISEE's average price target has moved up $10.86 over the prior 26 months.
ISEE reports an average of 68.83% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ISEE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 59 days, ISEE's average broker recommendation rating worsened by 0.14.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how IVERIC bio Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -75.75% of that group.
- In terms of how IVERIC bio Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 158.57% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, IVERIC bio Inc's average analyst price target is higher than 209.3% of them.
- ISEE has a higher number of analysts covering the stock than 236.18% of stocks in the mid market cap category.
What is the outlook for ISEE? Use POWR Ratings for clearer insight into price direction.